An exploratory clinical trial about the efficacy and safety of GLP-1 receptor agonist dulaglutide in maintenance hemodialysis patients with type 2 diabetes treated with insulin - An exploratory clinical trial about the efficacy and safety of GLP-1 receptor agonist dulaglutide in maintenance hemodialysis patients with type 2 diabetes treated with insulin

iigata University Graduate School of Medical and Dental Sciences Department of Applied Molecular Medicine0 sites14 target enrollmentOctober 11, 2016

Overview

Phase: 未知
Intervention: Not specified
Conditions: Not specified
Sponsor: iigata University Graduate School of Medical and Dental Sciences Department of Applied Molecular Medicine
Enrollment: 14
Status: Completed
Last Updated: 2 years ago

No summary available.

Registry

who.int

Start Date

October 11, 2016

End Date

March 3, 2019

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

iigata University Graduate School of Medical and Dental Sciences Department of Applied Molecular Medicine

•1\. Those with hypersensitivity to DPP\-4 inhibitors or GLP\-1 receptor agonists 2\. Those with serious diabetic ketosis, coma, or pre\-coma 3\. Those with severe active infection, serious trauma, or in the perioperative period 4\. Those with severe heart or liver dysfunction 5\. Those with problems shown as below: 1\) Pituitary gland or adrenal gland dysfunction 2\) In the status of impaired nutrition, starvation, irregular or insufficient dietary intake, or hyposthenia 3\) Excessive muscular exercise 4\) Heavy alcohol drinkers 6\. BMI \< 18\.5 kg/m2 7\. Those who are pregnant or beast\-feeding, or those who might be pregnant 8\. Those who are considered not eligible for this trial by attending doctors due to any medical reasons